Literature DB >> 19251697

Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation.

Alexandre Chigaev1, Anna Waller, Or Amit, Liliana Halip, Cristian G Bologa, Larry A Sklar.   

Abstract

Integrins are heterodimeric adhesion receptors that regulate immune cell adhesion. Integrin-dependent adhesion is controlled by multiple conformational states that include states with different affinity to the ligand, states with various degrees of molecule unbending, and others. Affinity change and molecule unbending play major roles in the regulation of cell adhesion. The relationship between different conformational states of the integrin is unclear. Here we have used conformationally sensitive antibodies and a small LDV-containing ligand to study the role of the inside-out signaling through formyl peptide receptor and CXCR4 in the regulation of alpha(4)beta(1) integrin conformation. We found that in the absence of ligand, activation by formyl peptide or SDF-1 did not result in a significant exposure of HUTS-21 epitope. Occupancy of the ligand binding pocket without cell activation was sufficient to induce epitope exposure. EC(50) for HUTS-21 binding in the presence of LDV was identical to a previously reported ligand equilibrium dissociation constant at rest and after activation. Furthermore, the rate of HUTS-21 binding was also related to the VLA-4 activation state even at saturating ligand concentration. We propose that the unbending of the integrin molecule after guanine nucleotide-binding protein-coupled receptor-induced signaling accounts for the enhanced rate of HUTS-21 binding. Taken together, current results support the existence of multiple conformational states independently regulated by both inside-out signaling and ligand binding. Our data suggest that VLA-4 integrin hybrid domain movement does not depend on the affinity state of the ligand binding pocket.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251697      PMCID: PMC2682882          DOI: 10.1074/jbc.M901178200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.

Authors:  Jian-Ping Xiong; Thilo Stehle; Rongguang Zhang; Andrzej Joachimiak; Matthias Frech; Simon L Goodman; M Amin Arnaout
Journal:  Science       Date:  2002-03-07       Impact factor: 47.728

Review 2.  Flow cytometric analysis of ligand-receptor interactions and molecular assemblies.

Authors:  Larry A Sklar; Bruce S Edwards; Steven W Graves; John P Nolan; Eric R Prossnitz
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001-10-25

Review 3.  From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts.

Authors:  Ronen Alon; Sara Feigelson
Journal:  Semin Immunol       Date:  2002-04       Impact factor: 11.130

Review 4.  Chemokines in rapid leukocyte adhesion triggering and migration.

Authors:  Brent Johnston; Eugene C Butcher
Journal:  Semin Immunol       Date:  2002-04       Impact factor: 11.130

5.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

6.  Real time analysis of the affinity regulation of alpha 4-integrin. The physiologically activated receptor is intermediate in affinity between resting and Mn(2+) or antibody activation.

Authors:  A Chigaev; A M Blenc; J V Braaten; N Kumaraswamy; C L Kepley; R P Andrews; J M Oliver; B S Edwards; E R Prossnitz; R S Larson; L A Sklar
Journal:  J Biol Chem       Date:  2001-10-18       Impact factor: 5.157

7.  Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling.

Authors:  Junichi Takagi; Benjamin M Petre; Thomas Walz; Timothy A Springer
Journal:  Cell       Date:  2002-09-06       Impact factor: 41.582

Review 8.  Integrin activation and structural rearrangement.

Authors:  Junichi Takagi; Timothy A Springer
Journal:  Immunol Rev       Date:  2002-08       Impact factor: 12.988

9.  Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins.

Authors:  Axel Lorentz; Detlef Schuppan; Andreas Gebert; Michael P Manns; Stephan C Bischoff
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

10.  Functional relevance of activated beta1 integrins in mercury-induced nephritis.

Authors:  Esther Escudero; Ana Martín; Marta Nieto; Elena Nieto; Elena Navarro; Alfonso Luque; Carlos Cabañas; Francisco Sánchez-Madrid; Francisco Mampaso
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

View more
  31 in total

1.  Discovery of very late antigen-4 (VLA-4, alpha4beta1 integrin) allosteric antagonists.

Authors:  Alexandre Chigaev; Yang Wu; D Bart Williams; Yelena Smagley; Larry A Sklar
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

2.  Structural requirements for activation in alphaIIb beta3 integrin.

Authors:  Tetsuji Kamata; Makoto Handa; Sonomi Ito; Yukiko Sato; Toshimitsu Ohtani; Yohko Kawai; Yasuo Ikeda; Sadakazu Aiso
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

3.  The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Authors:  Nunzia Montuori; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Valeria Visconte; Daniela Alfano; Ada Pesapane; Francesca Wanda Rossi; Salvatore Salzano; Guido Rossi; Pia Ragno
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

4.  Drug Repurposing from an Academic Perspective.

Authors:  Tudor I Oprea; Julie E Bauman; Cristian G Bologa; Tione Buranda; Alexandre Chigaev; Bruce S Edwards; Jonathan W Jarvik; Hattie D Gresham; Mark K Haynes; Brian Hjelle; Robert Hromas; Laurie Hudson; Debra A Mackenzie; Carolyn Y Muller; John C Reed; Peter C Simons; Yelena Smagley; Juan Strouse; Zurab Surviladze; Todd Thompson; Oleg Ursu; Anna Waller; Angela Wandinger-Ness; Stuart S Winter; Yang Wu; Susan M Young; Richard S Larson; Cheryl Willman; Larry A Sklar
Journal:  Drug Discov Today Ther Strateg       Date:  2011

5.  Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier.

Authors:  Slava Rom; Viviana Zuluaga-Ramirez; Holly Dykstra; Nancy L Reichenbach; Pal Pacher; Yuri Persidsky
Journal:  Am J Pathol       Date:  2013-09-18       Impact factor: 4.307

6.  Anti-αLβ2 antibodies reveal novel endocytotic cross-modulatory functionality.

Authors:  Riccardo V Mancuso; Jens Casper; Albrecht G Schmidt; Stephan Krähenbühl; Gabriele Weitz-Schmidt
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

Review 7.  Conformational Equilibrium of Human Platelet Integrin Investigated by Three-Dimensional Electron Cryo-Microscopy.

Authors:  Dorit Hanein; Niels Volkmann
Journal:  Subcell Biochem       Date:  2018

8.  Osteopontin binding to the alpha 4 integrin requires highest affinity integrin conformation, but is independent of post-translational modifications of osteopontin.

Authors:  Tommy Hui; Esben S Sørensen; Susan R Rittling
Journal:  Matrix Biol       Date:  2014-11-29       Impact factor: 11.583

9.  Conformational mAb as a tool for integrin ligand discovery.

Authors:  Ben H Njus; Alexandre Chigaev; Anna Waller; Danuta Wlodek; Liliana Ostopovici-Halip; Oleg Ursu; Wei Wang; Tudor I Oprea; Cristian G Bologa; Larry A Sklar
Journal:  Assay Drug Dev Technol       Date:  2009-10       Impact factor: 1.738

10.  Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment.

Authors:  Jian-Ping Xiong; Bhuvaneshwari Mahalingham; Jose Luis Alonso; Laura Ann Borrelli; Xianliang Rui; Saurabh Anand; Bradley T Hyman; Thomas Rysiok; Dirk Müller-Pompalla; Simon L Goodman; M Amin Arnaout
Journal:  J Cell Biol       Date:  2009-08-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.